Pfizer, Inc. (PFE)
A research-based, pharmaceutical Company which discovers, develops, manufactures and markets prescription medicines for humans and animals.
Recs
BLAYNE100
(87.42)
Submitted: 11/16/2009 8:46:42 PM :
Start Price:
$17.85
PFE Score:
+4.20
Strong Sector for 2010
Recs
devoish
(99.65)
Submitted: 11/12/2009 11:41:38 AM :
Start Price:
$17.75
PFE Score:
+3.41
Here is a company that has gamed the FDA process succesfully only to be found out later according to its history of fines. Their R&D has not delivered according to Fools, neither has Wyeth's, according to Fools. They are closing R&D facilities which makes sense if they haven't delivered a nice pipeline. They have cash and they will probably buy new R&D facilities and the companys that go with them. At least that's what I would do. Will Pfizer do it succesfully? From my vantage point as a mechanic I don't know, but I can guess. Outperform. No real life money though, this company should have been shut down, not just fined for its repetitive offenses.
Recs
WPThatcher
(61.60)
Submitted: 10/31/2009 3:36:38 PM :
Start Price:
$16.74
PFE Score:
+4.18
Well-run and cash-rich.. Demographics favor this company.
Recs
romaray
(< 20)
Submitted: 10/22/2009 2:02:37 PM :
Start Price:
$17.26
PFE Score:
-5.84
Changes in reimbursement as health care costs are rationalized.
Recs
stuinkc
(63.95)
Submitted: 10/22/2009 9:44:11 AM :
Start Price:
$17.29
PFE Score:
+4.59
value, dividend
Recs
Rheddrian
(< 20)
Submitted: 10/21/2009 3:42:12 PM :
Start Price:
$17.45
PFE Score:
+4.41
Cake Dex test run
Recs
vshar
(45.72)
Submitted: 10/21/2009 2:47:38 PM :
Start Price:
$17.51
PFE Score:
+5.18
After healthcare reforms the pimps will be gone and the benefit will go to the patients and indirectly to the pharmacuticals
Recs
Recs
germanjuggler
(< 20)
Submitted: 10/20/2009 5:15:31 AM :
Start Price:
$18.11
PFE Score:
+1.86
it is viagra for the S&P500
Recs
siri22
(26.95)
Submitted: 10/19/2009 3:04:47 PM :
Start Price:
$17.87
PFE Score:
+3.24
good company, meds for boomers, always chance for block buster drug
Recs
FrankieB213
(< 20)
Submitted: 10/15/2009 1:56:11 PM :
Start Price:
$17.25
PFE Score:
+6.32
I actually bought this stock under $16.50 months ago and have been waiting for this acquisition to take place. Right now everything is in place for this stock to break the $20 range by end of year. Plus they have a solid dividend that is not going anywhere anytime soon
Recs
fjm1502
(51.03)
Submitted: 10/12/2009 5:52:22 PM :
Start Price:
$16.73
PFE Score:
+7.83
Awesome company with 15 plus pending FDA approval for drugs.
Recs
joker11b
(60.06)
Submitted: 10/7/2009 9:23:51 AM :
Start Price:
$16.58
PFE Score:
+6.76
Flu epidemic. Current proposal to FDA over HIV medicine.
Recs
SequoiaStocks
(< 20)
Submitted: 9/18/2009 10:22:05 AM :
Start Price:
$16.46
PFE Score:
+8.85
This account tracks the performance of the investment firm Ruane, Cunniff, and Goldfarb - the investment manager of Sequoia Fund.
Recs
hirooshivam
(< 20)
Submitted: 9/8/2009 4:59:02 PM :
Start Price:
$16.11
PFE Score:
+7.36
global name known for decades and their research will get this stock ahead of their competitors
Recs
HarukanaruAo
(72.84)
Submitted: 8/27/2009 2:45:16 AM :
Start Price:
$16.30
PFE Score:
+2.82
The Wyeth acquisition will probably weigh down the stocks for a while, but gaining that pipeline of potential drugs and product should pay off in a couple of years. The management also seems to be devoted to streamlining research and development and to focusing on high-potential projects.
Recs
zsanabri
(< 20)
Submitted: 8/26/2009 6:49:10 PM :
Start Price:
$16.49
PFE Score:
+4.66
worked for the company for 28 years
Recs
charlesumeugokwe
(< 20)
Submitted: 8/25/2009 2:34:42 PM :
Start Price:
$16.62
PFE Score:
+3.77
astounding balance sheet
Recs
cashandgrab
(70.61)
Submitted: 8/24/2009 6:31:29 PM :
Start Price:
$16.59
PFE Score:
+4.25
Drug companies manufacture money in the form of little pills. The population is getting older and needs more pills to keep going, ergo: more money for Pfizer.
Recs
Prodders
(< 20)
Submitted: 8/17/2009 3:35:10 PM :
Start Price:
$15.77
PFE Score:
+4.85
Low P/E, solid company, getting very little value placed on the current pipeline. Looks reasonable timing on a technical basis too, having recently broken above the 200 day mva.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 940 1 2 3 4 5 6 7 8 9 10 Next »